Related Experiment Video
Updated: May 7, 2026
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
Design of B-Cell Multi-Epitope Subunit Vaccines Against Glaesserella parasuis by Reverse Vaccinology: An In Silico
1State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun, China, jlu.edu.cn.
None:
Glässer's disease caused by Glaesserella parasuis (GPS) is a severe disease that results in substantial economic losses to the swine industry worldwide. Here we describe a multiepitope vaccine cocktail (MEVC) that was designed using reverse vaccinology and immunoinformatics. The MEVC was comprised of three multiepitope subunits (MESs, designated as TB, 14B, and 24B), which were constructed using 14 B-cell epitopes predicted from six outer membrane antigens of GPS. The MESs exhibited non-allergenicity, high antigenicity, solubility, and stability. Predicted secondary and tertiary structures of the MESs were validated and showed strong binding affinity with the swine leukocyte antigen (SLA) by molecular docking. Immune simulation analysis further confirmed robust induction of both cellular and humoral immune responses. Immunization with MESs plus Gel-01 adjuvant (MEVC) resulted in 80% protection against GPS5 infection in mice, along with significantly increased antigen-specific IgG levels compared to controls. In conclusion, MEVC is a promising vaccine candidate to protect against porcine Glasser's disease.
More Related Videos
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
